Suppr超能文献

钙化性主动脉瓣狭窄的风险因素谱

Risk factor profile of calcific aortic stenosis.

作者信息

Sathyamurthy I, Alex Shaji, Kirubakaran K, Sengottuvelu G, Srinivasan K N

机构信息

Department of Cardiology, Apollo Main Hospital, Chennai, India.

Apollo Main Hospitals, India.

出版信息

Indian Heart J. 2016 Nov-Dec;68(6):828-831. doi: 10.1016/j.ihj.2016.04.007. Epub 2016 Apr 28.

Abstract

BACKGROUND

Calcific aortic stenosis and coronary artery disease share common risk factors. In some of the previous studies statins have been used to retard the progression of aortic stenosis, but the results were inconsistent.

METHODS

One hundred and ten patients of CAS above the age of 40 years have undergone clinical, biochemical and echocardiographic evaluation. Coronary angiograms were done in 66% of them.

RESULTS

Male to female ratio was 2:1. Patients of CAS with CAD showed higher prevalence of diabetes, hypertension, dyslipidemia, smoking and family history of CAD. Prevalence of obesity and bicuspid aortic valve by echocardiogram was high in those without CAD.

CONCLUSIONS

On comparison of prevalence of risk factor in those with and without associated CAD, there was higher prevalence of diabetes (65% vs 30%), hypertension (52% vs 43%), dyslipidemia (69% vs 52%), smoking (24% vs 18%) and family history of CAD (34% vs 16%) in those with associated CAD. The incidence of obesity was higher in those without CAD (20% vs 30%). The difference observed in diabetes alone was found to be statistically significant.

摘要

背景

钙化性主动脉瓣狭窄与冠状动脉疾病有共同的危险因素。在一些先前的研究中,他汀类药物已被用于延缓主动脉瓣狭窄的进展,但结果并不一致。

方法

110例40岁以上的钙化性主动脉瓣狭窄患者接受了临床、生化和超声心动图评估。其中66%的患者进行了冠状动脉造影。

结果

男女比例为2:1。合并冠心病的钙化性主动脉瓣狭窄患者糖尿病、高血压、血脂异常、吸烟及冠心病家族史的患病率更高。无冠心病患者经超声心动图检查发现肥胖和二叶式主动脉瓣的患病率较高。

结论

比较合并冠心病和未合并冠心病患者的危险因素患病率,合并冠心病患者糖尿病(65%对30%)、高血压(52%对43%)、血脂异常(69%对52%)、吸烟(24%对18%)及冠心病家族史(34%对16%)的患病率更高。无冠心病患者肥胖的发生率更高(20%对30%)。仅糖尿病方面观察到的差异具有统计学意义。

相似文献

1
Risk factor profile of calcific aortic stenosis.
Indian Heart J. 2016 Nov-Dec;68(6):828-831. doi: 10.1016/j.ihj.2016.04.007. Epub 2016 Apr 28.
2
Does aortic valve sclerosis predicts the severity and complexity of coronary artery disease?
Indian Heart J. 2015 May-Jun;67(3):239-44. doi: 10.1016/j.ihj.2015.03.010. Epub 2015 Apr 27.
4
Osseous and chondromatous metaplasia in calcific aortic valve stenosis.
Cardiovasc Pathol. 2016 Jan-Feb;25(1):18-24. doi: 10.1016/j.carpath.2015.08.008. Epub 2015 Aug 29.
7
Aortic valve calcification: its significance and limitation as a marker for coronary artery disease.
Angiology. 2002 Mar-Apr;53(2):165-9. doi: 10.1177/000331970205300206.
9
The influence of aortic valve calcification on the risk of periprocedural myocardial injury after elective coronary intervention.
Aging Clin Exp Res. 2015 Oct;27(5):631-6. doi: 10.1007/s40520-015-0336-1. Epub 2015 Mar 5.

引用本文的文献

1
Could the Hemodynamic Progression of Aortic Valve Stenosis be Slowed Pharmacologically? The Unsolved Dilemma.
Rev Cardiovasc Med. 2025 Feb 12;26(2):26537. doi: 10.31083/RCM26537. eCollection 2025 Feb.
2
Risk Factors for Calcific Aortic Valve Disease in Afghan Population.
Vasc Health Risk Manag. 2022 Aug 18;18:643-652. doi: 10.2147/VHRM.S376955. eCollection 2022.
4
Diabetes Mellitus and Its Implications in Aortic Stenosis Patients.
Int J Mol Sci. 2021 Jun 9;22(12):6212. doi: 10.3390/ijms22126212.
5
Degenerative Aortic Stenosis, Dyslipidemia and Possibilities of Medical Treatment.
Medicina (Kaunas). 2018 Apr 25;54(2):24. doi: 10.3390/medicina54020024.

本文引用的文献

1
Calcific aortic valve disease: is it another face of atherosclerosis?
Indian Heart J. 2015 Sep-Oct;67(5):503-6. doi: 10.1016/j.ihj.2015.07.033. Epub 2015 Aug 21.
3
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
N Engl J Med. 2008 Sep 25;359(13):1343-56. doi: 10.1056/NEJMoa0804602. Epub 2008 Sep 2.
5
Calcific aortic stenosis: an update.
Nat Clin Pract Cardiovasc Med. 2007 May;4(5):254-62. doi: 10.1038/ncpcardio0827.
6
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.
Am J Cardiol. 2007 Apr 1;99(7):970-3. doi: 10.1016/j.amjcard.2006.10.064. Epub 2007 Feb 15.
7
Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.
J Am Coll Cardiol. 2007 Feb 6;49(5):554-61. doi: 10.1016/j.jacc.2006.07.072. Epub 2007 Jan 22.
8
Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway.
Circulation. 2005 Aug 30;112(9 Suppl):I229-34. doi: 10.1161/01.CIRCULATIONAHA.104.524306.
9
A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.
N Engl J Med. 2005 Jun 9;352(23):2389-97. doi: 10.1056/NEJMoa043876.
10
An echocardiographic survey of primary school children for bicuspid aortic valve.
Am J Cardiol. 2004 Mar 1;93(5):661-3. doi: 10.1016/j.amjcard.2003.11.031.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验